Search

David A. Reifsnyder

Examiner (ID: 7507, Phone: (571)272-1145 , Office: P/1778 )

Most Active Art Unit
1723
Art Unit(s)
1797, 1778, 1776, 2899, 1723, 1306
Total Applications
2074
Issued Applications
1659
Pending Applications
148
Abandoned Applications
274

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7126966 [patent_doc_number] => 20050058710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Porous drug matrices and methods of manufacture thereof' [patent_app_type] => utility [patent_app_number] => 10/928886 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10762 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058710.pdf [firstpage_image] =>[orig_patent_app_number] => 10928886 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/928886
Porous drug matrices and methods of manufacture thereof Aug 26, 2004 Abandoned
Array ( [id] => 876370 [patent_doc_number] => 07358226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Ultrasonic concentration of drug delivery capsules' [patent_app_type] => utility [patent_app_number] => 10/928648 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 21094 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358226.pdf [firstpage_image] =>[orig_patent_app_number] => 10928648 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/928648
Ultrasonic concentration of drug delivery capsules Aug 25, 2004 Issued
Array ( [id] => 7436350 [patent_doc_number] => 20040266869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Novel medicament compositions based on anticholinesterase drugs and on ciclesonides' [patent_app_type] => new [patent_app_number] => 10/465921 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7380 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266869.pdf [firstpage_image] =>[orig_patent_app_number] => 10465921 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/465921
Novel medicament compositions based on anticholinesterase drugs and on ciclesonides Aug 25, 2004 Abandoned
Array ( [id] => 6966002 [patent_doc_number] => 20050232899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b' [patent_app_type] => utility [patent_app_number] => 10/927518 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9920 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232899.pdf [firstpage_image] =>[orig_patent_app_number] => 10927518 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/927518
Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b Aug 24, 2004 Abandoned
Array ( [id] => 7175803 [patent_doc_number] => 20050123486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Medical product containing tiotropium' [patent_app_type] => utility [patent_app_number] => 10/921192 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8686 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123486.pdf [firstpage_image] =>[orig_patent_app_number] => 10921192 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/921192
Medical product containing tiotropium Aug 18, 2004 Abandoned
Array ( [id] => 7026459 [patent_doc_number] => 20050020502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Sincalide formulations' [patent_app_type] => utility [patent_app_number] => 10/921732 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15539 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020502.pdf [firstpage_image] =>[orig_patent_app_number] => 10921732 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/921732
Sincalide formulations Aug 18, 2004 Abandoned
Array ( [id] => 5590418 [patent_doc_number] => 20060039869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Intranasal delivery of antipsychotic drugs' [patent_app_type] => utility [patent_app_number] => 10/920153 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4299 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039869.pdf [firstpage_image] =>[orig_patent_app_number] => 10920153 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/920153
Intranasal delivery of antipsychotic drugs Aug 16, 2004 Abandoned
Array ( [id] => 7249098 [patent_doc_number] => 20040258623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Insulin-containing oral spray and the preparation method thereof' [patent_app_type] => new [patent_app_number] => 10/486461 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2942 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258623.pdf [firstpage_image] =>[orig_patent_app_number] => 10486461 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/486461
Insulin-containing oral spray and the preparation method thereof Aug 12, 2004 Abandoned
Array ( [id] => 7265099 [patent_doc_number] => 20040242635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Encapsulated dyes in cosmetic compositions' [patent_app_type] => new [patent_app_number] => 10/432762 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1918 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242635.pdf [firstpage_image] =>[orig_patent_app_number] => 10432762 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/432762
Encapsulated dyes in cosmetic compositions Aug 5, 2004 Abandoned
Array ( [id] => 363186 [patent_doc_number] => 07481996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Aerosol cosmetic composition' [patent_app_type] => utility [patent_app_number] => 10/911488 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7111 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/481/07481996.pdf [firstpage_image] =>[orig_patent_app_number] => 10911488 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/911488
Aerosol cosmetic composition Aug 4, 2004 Issued
Array ( [id] => 7199856 [patent_doc_number] => 20050042179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine' [patent_app_type] => utility [patent_app_number] => 10/909619 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3872 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042179.pdf [firstpage_image] =>[orig_patent_app_number] => 10909619 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909619
Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine Aug 1, 2004 Abandoned
Array ( [id] => 7199858 [patent_doc_number] => 20050042180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder' [patent_app_type] => utility [patent_app_number] => 10/909624 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5440 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042180.pdf [firstpage_image] =>[orig_patent_app_number] => 10909624 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909624
Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder Aug 1, 2004 Abandoned
Array ( [id] => 7127899 [patent_doc_number] => 20050059643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Medicaments for inhalation comprising a steroid and a betamimetic' [patent_app_type] => utility [patent_app_number] => 10/903769 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7470 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059643.pdf [firstpage_image] =>[orig_patent_app_number] => 10903769 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/903769
Medicaments for inhalation comprising a steroid and a betamimetic Jul 29, 2004 Abandoned
Array ( [id] => 7206293 [patent_doc_number] => 20050043247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative' [patent_app_type] => utility [patent_app_number] => 10/902305 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4166 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043247.pdf [firstpage_image] =>[orig_patent_app_number] => 10902305 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/902305
Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative Jul 28, 2004 Abandoned
Array ( [id] => 7199853 [patent_doc_number] => 20050042178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder' [patent_app_type] => utility [patent_app_number] => 10/901791 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4905 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042178.pdf [firstpage_image] =>[orig_patent_app_number] => 10901791 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/901791
Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder Jul 28, 2004 Abandoned
Array ( [id] => 7159422 [patent_doc_number] => 20050084457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Capsules containing inhalable tiotropium' [patent_app_type] => utility [patent_app_number] => 10/901790 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6565 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084457.pdf [firstpage_image] =>[orig_patent_app_number] => 10901790 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/901790
Capsules containing inhalable tiotropium Jul 28, 2004 Abandoned
Array ( [id] => 7192745 [patent_doc_number] => 20050163725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Method for administration of growth hormone via pulmonary delivery' [patent_app_type] => utility [patent_app_number] => 10/900992 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5607 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163725.pdf [firstpage_image] =>[orig_patent_app_number] => 10900992 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/900992
Method for administration of growth hormone via pulmonary delivery Jul 27, 2004 Abandoned
Array ( [id] => 860456 [patent_doc_number] => 07371727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Methods and compositions for the treatment of gastrointestinal disorders' [patent_app_type] => utility [patent_app_number] => 10/899806 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 33985 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371727.pdf [firstpage_image] =>[orig_patent_app_number] => 10899806 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/899806
Methods and compositions for the treatment of gastrointestinal disorders Jul 26, 2004 Issued
Array ( [id] => 7199852 [patent_doc_number] => 20050042177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Novel compositions of sildenafil free base' [patent_app_type] => utility [patent_app_number] => 10/895405 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17297 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042177.pdf [firstpage_image] =>[orig_patent_app_number] => 10895405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/895405
Novel compositions of sildenafil free base Jul 20, 2004 Abandoned
Array ( [id] => 6971242 [patent_doc_number] => 20050036952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Compositions and methods for the treatment of aches and pains' [patent_app_type] => utility [patent_app_number] => 10/895243 [patent_app_country] => US [patent_app_date] => 2004-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5284 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20050036952.pdf [firstpage_image] =>[orig_patent_app_number] => 10895243 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/895243
Compositions and methods for the treatment of aches and pains Jul 18, 2004 Abandoned
Menu